会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Process for the preparation of a non-corrosive base solution and methods of using same
    • 非腐蚀性碱溶液的制备方法及其使用方法
    • US08273384B2
    • 2012-09-25
    • US12167123
    • 2008-07-02
    • Stephen Ray Wurzberger
    • Stephen Ray Wurzberger
    • A61K33/08A61K33/04A01N59/02A01N59/06
    • A61K33/08A61K45/06C09K15/02
    • The present invention provides novel methods of making a non-corrosive base solution for use as an alkalinity increasing agent and/or antioxidant. The present invention further provides novel compositions and methods which can be used to provide relief from disorders related to or complicated by acidosis or excessive free radical or other reactive oxygen species production including, but not limited to, gout, Lesch-Nyhan syndrome, hemochromatosis, Alzheimer's, amyotropic lateral sclerosis, arthritis, atherosclerosis, cancer, cataracts, chronic obstructive pulmonary disease, diabetes, cellulitis, coronary artery disease, heart failure, hypertension, inflammatory bowel disease, macular degeneration, multiple sclerosis, Parkinson's, Reynaud's phenomenon, reperfusion injury, pancreatic impairment, skin infections, Hepatitis C, methicillin-resistant Staphylococcus aureus and infection. The compositions and methods of the present invention additionally supply relief from microbial infections including fungal infections as well as prevent secondary infections. Additional compositions and methods are provided which employ a non-corrosive base solution in combination with a second alkalinity increasing agent and/or antioxidant, or other therapeutic agent to yield a more effective treatment tool against acidosis and/or excessive ROS production including free radical production useful to prevent or reduce acidosis and/or excessive ROS production or related symptoms or conditions associated with acidosis and/or excessive free radical production in mammalian subjects.
    • 本发明提供了制备用作碱性增加剂和/或抗氧化剂的非腐蚀性碱溶液的新方法。 本发明还提供了新的组合物和方法,其可用于缓解与酸中毒或过量自由基或其他活性氧物质产生相关或复杂的紊乱,包括但不限于痛风,Lesch-Nyhan综合征,血色素沉着症, 阿尔茨海默氏症,肌萎缩性侧索硬化,关节炎,动脉粥样硬化,癌症,白内障,慢性阻塞性肺病,糖尿病,蜂窝织炎,冠状动脉疾病,心力衰竭,高血压,炎性肠病,黄斑变性,多发性硬化,帕金森病,雷诺氏现象,再灌注损伤, 胰腺损伤,皮肤感染,丙型肝炎,耐甲氧西林金黄色葡萄球菌和感染。 本发明的组合物和方法另外还提供了微生物感染的缓解,包括真菌感染以及预防继发性感染。 提供了另外的组合物和方法,其采用非腐蚀性碱溶液与第二碱性增加剂和/或抗氧化剂或其它治疗剂组合以产生更有效的治疗工具来防止酸中毒和/或过量的ROS产生,包括自由基生成 可用于预防或减少酸中毒和/或过量的ROS产生或与哺乳动物受试者的酸中毒和/或过量自由基产生相关的相关症状或症状。
    • 7. 发明授权
    • Chemical inhibitors of inhibitors of differentiation
    • 分化抑制剂的化学抑制剂
    • US08138356B2
    • 2012-03-20
    • US12253009
    • 2008-10-16
    • Jaideep ChaudharyWilliam A. Garland
    • Jaideep ChaudharyWilliam A. Garland
    • C07D409/02A61K31/33
    • A01K67/0271A01K2207/20A01K2227/105A01K2267/0331A61K31/165A61K31/38A61K45/06A61K2300/00
    • The present invention provides identification of inhibitors of inhibitors of differentiation (Id) for use in the treatment and prevention of diseases in mammals. The inhibitors of Id are effective alone in the treatment of a variety of cellular proliferative disorders including, but not limited to, diseases such as cancer, arthritis, age-related macular degeneration, psoriasis, neoplasms, angiomas, endometriosis, obesity, age-related macular degeneration, retinopathies, restenosis, scaring, fibrogenesis, fibrosis, cardiac remodeling, pulmonary fibrosis, scleroderma, failure associated with myocardial infarction, keloids, fibroid tumors and stenting. Additionally, these compounds are effective in blocking angiogenesis in tumor development, inducing apoptosis in malignant cells, inhibiting proliferation of cancer cells, increasing the effectiveness of chemotherapeutic agents, regulating transcriptional activity, reducing inflammation, increasing cellular differentiation, modulating ETS domain transcription factors, modulating PAX transcription factors, modulating TCF-ETS domain transcription factors, down regulating RAF-1/MAPK, upregulating JNK signaling pathways, and modulating cellular transformation.
    • 本发明提供用于治疗和预防哺乳动物疾病的分化抑制剂抑制剂(Id)的鉴定。 Id的抑制剂单独用于治疗各种细胞增殖性疾病,包括但不限于疾病如癌症,关节炎,年龄相关性黄斑变性,牛皮癣,肿瘤,血管瘤,子宫内膜异位症,肥胖症,年龄相关 黄斑变性,视网膜病变,再狭窄,惊厥,纤维发生,纤维化,心脏重塑,肺纤维化,硬皮病,与心肌梗塞相关的衰竭,瘢痕疙瘩,纤维瘤和支架置入术。 此外,这些化合物有效阻断肿瘤发展中的血管生成,诱导恶性细胞凋亡,抑制癌细胞增殖,增加化疗药物的有效性,调节转录活性,减少炎症,增加细胞分化,调节ETS结构域转录因子,调节 PAX转录因子,调节TCF-ETS结构域转录因子,调控RAF-1 / MAPK,上调JNK信号通路,调节细胞转化。
    • 8. 发明授权
    • 2-Nitratoethyl oxirane, poly (2-nitratoethyl oxirane) and preparation method thereof
    • 2-硝基乙基环氧乙烷,聚(2-硝基乙基环氧乙烷)及其制备方法
    • US07880023B2
    • 2011-02-01
    • US12431754
    • 2009-04-28
    • Jin Seuk KimJin Rai ChoKeun Deuk LeeJeong-Kook Kim
    • Jin Seuk KimJin Rai ChoKeun Deuk LeeJeong-Kook Kim
    • C07D303/08
    • C07D303/08C08G65/22C08G65/2609
    • A synthesis of an energetic prepolymer used as a high-energy binder for an insensitive and high performance explosive is disclosed. More specifically, provided are a novel compound 2-nitratoethyl oxirane expressed by formula III, a novel compound poly(2-nitratoethyl oxirane) expressed by formula IV, obtained by polymerization of 2-nitratoethyl oxirane used as a monomer and a preparation method thereof. The compound, used as an energetic prepolymer and a monomer for preparation thereof can substitute for existing poly(glycidyl nitrate) (PGN) which has been known to be a promising one having the best performance among existing energetic prepolymers, but which has a problem to be self-decomposed after synthesis of polyurethane elastomer, to solve this problem.
    • 公开了用作不敏感和高性能炸药的高能粘合剂的能量预聚物的合成。 更具体地说,提供了由式III表示的新型化合物2-硝基乙基环氧乙烷,通过用作单体的2-硝基乙基环氧乙烷的聚合获得的式IV表示的新型化合物聚(2-硝基乙基环氧乙烷)及其制备方法。 用作能量预聚物的化合物和用于制备其的单体可以代替已知在现有能量预聚物中具有最佳性能的有前途的聚(缩水甘油基硝酸酯)(PGN),但是具有问题 在聚氨酯弹性体合成后自行分解,解决这个问题。